News
2025 News Archive
Prototyping the Future of Fertility Innovation with Clinicians and Companies
December 10, 2025
The matchmaking and co-creation event brought together startups, clinicians, researchers, and industry with the aim of exploring how collaboration and testbed frameworks can help accelerate innovation in the field of reproductive medicine.
Men’s role in fertility: An overlooked key to family and public health
November 26, 2025
At the 2025 ASRM Scientific Congress in October, Aleksander Giwercman delivered a keynote, highlighting the health of the male partner as a crucial aspect of fertility and the need for a couple-centered approach.
November 24, 2025
In November ReproUnion joined leading voices in cross-border innovation at the 2025 Medicon Valley Alliance Annual Summit 2025 – a day where EU competitiveness met health innovation in practice.
ReproUnion Researcher receives grant to advance eHealth Support for Infertility
October 27, 2025
Congratulations to Eva Elmerstig and her research team on the SEK 2 million grant from the Mats Paulsson Foundation to advance their work on eHealth support for involuntary childlessness.
RUBIC reaches 2,000 couples – and a milestone for fertility research
September 19, 2025
ReproUnion celebrated the milestone with all contributing fertility and reproductive clinics who play a crucial role in collecting and processing the biological material and data that makes RUBIC possible.
ReproUnion Researchers Join BII Summer School in Entrepreneurship
September 17, 2025
By blending expert lectures with practical exercises, the course equipped the participants with insights and tools, which they can put directly into practice, if they wish to pursue the journey from science to commercialisation.
ReproTalk features internationally renowned standard for protecting future female fertility
September 12, 2025
The third ReproTalk event on 8 September tuned in on how researchers and clinicians at Rigshospitalet are helping to set the global standard for fertility preservation ahead of treatments that may harm the reproductive potential for both girls and women.
New study investigates the impact of paracetamol on women’s fertility based on samples from RUBIC
August 27, 2025
It builds on research published in Human Reproduction showing that paracetamol may impair the development of the fertilized egg in the very first days after conception.
ReproUnion at Folkemødet 2025: Fertility in focus with a strong public response
June 20, 2025
There is so much to be said about the ovaries in relation to fertility and many young women showed genuine interest in learning about their own biology, while having thoughtful discussions with Stine Gry Kristensen and Sandra Søgaard Tøttenborg.
PhD students complete the SmiLe e-Campus Innovation Course
June 16, 2025
Between April and June, nine ReproUnion-affiliated young researchers and doctors participated the 12-week online e-Campus Innovation Course, a programme developed in collaboration with SmiLe Venture Hub. The course is designed to support early-stage scientists in exploring how their research can be developed into solutions with real-world impact. Over the course of 8 modules, the participants […]
Mental Health Week: More support is needed through the emotional burden of infertility
June 6, 2025
The European Mental Health Week was a timely opportunity to shed light on the emotional strain that fertility treatments place on individuals and couples. By addressing both medical and emotional needs, a ReproUnion Innovation project aspires to support fertility treatment to make it more effective, less isolating, and more humane.
RUBIC in new industry collaboration with the use of MiOXSYS to analyze 1000 semen samples
May 28, 2025
As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in semen.
ReproTalk #2: Full House and fresh insights on infertility
May 28, 2025
At the event organized by ReproYoung the topic was male and female infertility – assessment and prognostic factors with talks by Anja Pinborg and Niels Jørgensen from Rigshospitalet.
First podcast with ReproUnion highlights several perspectives of involuntary childlessness
April 30, 2025
This third episode of the Business Review Life Science podcast series brings together diverse perspectives from academia, industry, and healthcare and dives into the urgent topic of involuntary childlessness and explores how public-private collaboration is key to finding innovative fertility solutions.
March 21, 2025
Human Reproduction has published the findings from the largest existing study, to examine the link between semen quality and mortality, based on data from nearly 80,000 men. The main authors are also part of ReproUnion.
March 18, 2025
Dx4Life is the first start-up to emerge from the ReproUnion Innovation Platform, and the collaboration with RMC is a strong example of the translational research that ReproUnion fosters to bridge the gap between laboratory discoveries and clinical application.
Innovation workshop sparks entrepreneurial thinking amongst clinicians
February 28, 2025
At the workshop, co-organized with LU Innovation and Reproduktionmedicinskt Centrum (RMC), the clinicians explored an innovation framework which underlines the distinction that an invention isn't truly an innovation until it’s successfully implemented.
ReproYoung 2.0 launches with a new ReproTalk series
February 26, 2025
ReproUnion hosted ReproYoung 2.0 for their re-launch and first ReproTalk event to explore parenthood – Is it important to have children? and what happens when biology becomes an enemy?